{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:16:44Z","timestamp":1768457804562,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.numecd.2015.10.009","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T23:34:57Z","timestamp":1446248097000},"page":"109-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study"],"prefix":"10.1016","volume":"26","author":[{"given":"F.","family":"Tavaglione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fallarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mandosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Turinese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2015.10.009_bib1","series-title":"International Diabetes Federation diabetes atlas","year":"2013"},{"key":"10.1016\/j.numecd.2015.10.009_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2015.10.009_bib3","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/JME-12-0156","article-title":"Therapeutic potential of VIP vs PACAP in diabetes","volume":"49","author":"Sanlioglu","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.numecd.2015.10.009_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.numecd.2015.10.009_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","article-title":"VPAC and PAC receptors: from ligands to function","volume":"121","author":"Dickson","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.numecd.2015.10.009_bib6","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.peptides.2007.04.024","article-title":"Role of VIP and PACAP in islet function","volume":"28","author":"Winzell","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.numecd.2015.10.009_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-001-0291-5","article-title":"Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases","volume":"80","author":"Delgado","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.numecd.2015.10.009_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(96)00063-X","article-title":"Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes","volume":"68","author":"Delgado","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.numecd.2015.10.009_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0196-9781(96)00070-8","article-title":"Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets","volume":"17","author":"Delgado","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.numecd.2015.10.009_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0167-0115(96)00024-9","article-title":"Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages","volume":"62","author":"Delgado","year":"1996","journal-title":"Regul Pept"},{"key":"10.1016\/j.numecd.2015.10.009_bib11","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1073\/pnas.92.7.2939","article-title":"Structure, expression and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene","volume":"92","author":"Sreedharan","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2015.10.009_bib12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.peptides.2007.04.026","article-title":"Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology","volume":"28","author":"Laburthe","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.numecd.2015.10.009_bib13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2174\/138161207780618966","article-title":"Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator","volume":"13","author":"Gonzalez-Rey","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.numecd.2015.10.009_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.23482","article-title":"Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells","volume":"58","author":"Delgado","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.numecd.2015.10.009_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/gene.2008.60","article-title":"A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia","volume":"9","author":"Paladini","year":"2008","journal-title":"Genes Immun"},{"key":"10.1016\/j.numecd.2015.10.009_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2982.2009.01284.x","article-title":"Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene","volume":"21","author":"Paladini","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.numecd.2015.10.009_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.gene.2011.11.055","article-title":"Gender-dependent association of type 2 diabetes with the vasoactive intestinal peptide receptor 1","volume":"493","author":"Paladini","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.numecd.2015.10.009_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.numecd.2015.10.009_bib19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2015.10.009_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncpendmet1066","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.numecd.2015.10.009_bib21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2015.10.009_bib22","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.numecd.2015.10.009_bib23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0024-3205(00)01023-7","article-title":"Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells","volume":"68","author":"Li","year":"2001","journal-title":"Life Sci"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T04:59:23Z","timestamp":1537246763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475315002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0939475315002227"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2015.10.009","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2015.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}